Free Trial

Hemenway Trust Co LLC Has $26.83 Million Position in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Hemenway Trust Co LLC grew its position in Xylem Inc. (NYSE:XYL - Free Report) by 5.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 224,613 shares of the industrial products company's stock after acquiring an additional 12,020 shares during the period. Xylem comprises about 2.2% of Hemenway Trust Co LLC's portfolio, making the stock its 22nd largest holding. Hemenway Trust Co LLC owned 0.09% of Xylem worth $26,832,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Birch Hill Investment Advisors LLC boosted its position in Xylem by 9.2% during the first quarter. Birch Hill Investment Advisors LLC now owns 2,875 shares of the industrial products company's stock worth $343,000 after purchasing an additional 242 shares during the period. Berkshire Bank raised its position in shares of Xylem by 11.2% in the first quarter. Berkshire Bank now owns 4,878 shares of the industrial products company's stock valued at $583,000 after purchasing an additional 490 shares during the period. Grove Bank & Trust lifted its stake in shares of Xylem by 90.9% during the 1st quarter. Grove Bank & Trust now owns 481 shares of the industrial products company's stock worth $57,000 after buying an additional 229 shares during the last quarter. Grimes & Company Inc. acquired a new stake in shares of Xylem during the 1st quarter worth about $13,096,000. Finally, Mountain Pacific Investment Advisers LLC boosted its holdings in shares of Xylem by 0.7% during the 1st quarter. Mountain Pacific Investment Advisers LLC now owns 313,152 shares of the industrial products company's stock worth $37,409,000 after buying an additional 2,060 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Trading Down 1.7%

Shares of NYSE XYL opened at $125.37 on Wednesday. The firm has a 50 day moving average price of $121.31 and a two-hundred day moving average price of $121.73. The stock has a market cap of $30.51 billion, a P/E ratio of 33.70, a price-to-earnings-growth ratio of 2.32 and a beta of 1.13. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $143.50. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.41 and a current ratio of 1.89.

Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.95 by $0.08. The business had revenue of $2.07 billion for the quarter, compared to analysts' expectations of $2.04 billion. Xylem had a return on equity of 10.12% and a net margin of 10.54%. The firm's revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.90 earnings per share. As a group, equities analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Thursday, May 29th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, May 29th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.28%. Xylem's payout ratio is presently 43.01%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on XYL. Robert W. Baird dropped their target price on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Raymond James Financial raised shares of Xylem to a "hold" rating in a report on Thursday, May 15th. JPMorgan Chase & Co. assumed coverage on shares of Xylem in a report on Friday, May 30th. They set an "overweight" rating and a $148.00 target price on the stock. Citigroup dropped their price target on shares of Xylem from $152.00 to $134.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Finally, Royal Bank Of Canada increased their price target on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Xylem has an average rating of "Moderate Buy" and an average target price of $143.71.

Check Out Our Latest Report on Xylem

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines